Intermittent Claudication News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Intermittent Claudication Analysis by Stage of Development, Route of Administration, and Molecule Type - Medgadget (blog)



Intermittent Claudication Analysis by Stage of Development, Route of Administration, and Molecule Type 
Medgadget (blog)
?Intermittent Claudication-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Intermittent Claudication. The report provides a complete understanding of the pipeline ...

and more » 


Lab-On-a-Chip Market ? Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017-2025 - Medgadget (blog)



Lab-On-a-Chip Market ? Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017-2025 
Medgadget (blog)
Also, there is observable rise in peripheral vascular disorders such as claudication, arteriosclerosis obliterans and intermittent claudication. Furthermore, with an increase in healthcare investment the market growth of LOC devices is expected to gain ...

 


PROPEL: Cell therapy does not boost walking performance in PAD - Healio



PROPEL: Cell therapy does not boost walking performance in PAD 
Healio
They used a 2-by-2 factorial design in which 210 participants with PAD, with and without classic intermittent claudication, were randomly assigned from 2012 to 2016 to one of four groups: GM-CSF plus exercise, GM-CSF plus attention control, supervised ...

and more » 


USMLE Step 2: How do you manage a throbbing headache? - American Medical Association (blog)



USMLE Step 2: How do you manage a throbbing headache? 
American Medical Association (blog)
An 82-year-old woman comes to the physician because of a right-sided throbbing headache, which has occurred intermittently for two weeks. She has also had ... Temporal arteritis (GCA): headache, visual disturbances, PMR, jaw claudication. High ESR plus ...

 


Selectin Inhibition Justifies GlycoMimetics Investment - Seeking Alpha



Seeking Alpha
 
Selectin Inhibition Justifies GlycoMimetics Investment 
Seeking Alpha
The market for the treatment of SCA is expected to reach about $600 million by 2025. Potential label expansion opportunities include intermittent claudication, peripheral artery disease, and other disorders mediated by inflammatory cytokines. The ...
Glycomimetics, Inc. - GLYC - Stock Price Today - Zacks Zacks Investment Research
GLYC GlycoMimetics, Inc. Stock Quote - Finviz Finviz

all 31 news articles » 


Neurogenic Intermittent Claudication Market Forecast 2022: Top Companies, Trends and Growth Factors Details for ... - satPRnews (press release)



Neurogenic Intermittent Claudication Market Forecast 2022: Top Companies, Trends and Growth Factors Details for ... 
satPRnews (press release)
Neurogenic Intermittent Claudication Market Research Report covers the present scenario and the growth prospects of Neurogenic Intermittent Claudication Industry for 2016-2021. Report covers the market landscape and its growth prospects over the coming ...

 


Peripheral Artery Disease - TG Daily (blog)



TG Daily (blog)
 
Peripheral Artery Disease 
TG Daily (blog)
This pain is called intermittent claudication, which can be felt during physical exercises, but it passes during rest. When the condition worsens, pain in the leg may appear with minimal activity or even during rest. Apart from the pain, other signs of ...

and more » 


Neurogenic Intermittent Claudication Market Key Player, Regions, Manufacturers Analysis, Application and ... - MilTech



Neurogenic Intermittent Claudication Market Key Player, Regions, Manufacturers Analysis, Application and ... 
MilTech
The Neurogenic Intermittent Claudication market report introduce incorporates analysis of definitions, classifications, applications and industry chain structure. The Neurogenic Intermittent Claudication industry report firstly announced the Neurogenic ...

and more » 


Evolocumab Reduces Risk of Cardiac Events for Peripheral Artery Disease - MD Magazine



MD Magazine
 
Evolocumab Reduces Risk of Cardiac Events for Peripheral Artery Disease 
MD Magazine
At baseline, 69% had intermittent claudication and ABI <0.85 and 57% had peripheral revascularization for a median of 3.7 years. Twenty-six percent of patients had both conditions. Those in the PAD group were 64 years of age, 28% were female, and 69% ...

and more » 


Intermittent Spinal Claudication Market Sales Segmentation and Analysis by Recent Trends, Development and Growth ... - MilTech



Intermittent Spinal Claudication Market Sales Segmentation and Analysis by Recent Trends, Development and Growth ... 
MilTech
Intermittent Spinal Claudication Market research report is a professional and in-depth study on the current state of Intermittent Spinal Claudication Industry. This Market Research report focuses on the major drivers and restraints for the key players.

and more »